Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Ah-Soune, P.
22  Ergebnisse:
Personensuche X
?
1

P903 Persistence, efficacy and tolerance of subcutaneous In..:

Mathieu, N ; Heluwaert, F ; Riviere, P...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1655-i1655 , 2024
Link: https://doi.org/10.1093/..
 
?
2

Efficacy, Tolerability, and Safety of Low-Volume Bowel Prep..:

Briot, C ; Faure, P ; Parmentier, A L...
Journal of Crohn's and Colitis.  13 (2019)  9 - p. 1121-1130 , 2019
Link: https://doi.org/10.1093/..
 
?
3

Impact de la formation médicale en nutrition sur la prise e..:

Mercky, P. ; Zeriguine, R. ; Garnero, A...
Nutrition Clinique et Métabolisme.  32 (2018)  4 - p. 267 , 2018
Link: https://doi.org/10.1016/..
 
?
4

Long-term consequences of bile duct injury after cholecyste..:

Barbier, L. ; Souche, R. ; Slim, K..
Journal of Visceral Surgery.  151 (2014)  4 - p. 269-279 , 2014
Link: https://doi.org/10.1016/..
 
?
5

Ectopie du pancréas jéjunal : une cause exceptionnelle d'hé..:

Ah-Soune, P. ; Vitton, V. ; Subtil, C....
Gastroentérologie Clinique et Biologique.  32 (2008)  2 - p. 202-204 , 2008
Link: https://doi.org/10.1016/..
 
?
6

P927 Long-term outcomes of risankizumab in Crohn's disease:..:

Fumery, M ; Caron, B ; Hébuterne, X...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1686-i1686 , 2024
Link: https://doi.org/10.1093/..
 
?
7

P404 Persistence of subcutaneous infliximab after switching..:

Mathieu, N ; Riviere, P ; Heluwaert, F...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i533-i534 , 2023
Link: https://doi.org/10.1093/..
 
?
8

P638 Effectiveness and safety of risankizumab induction the..:

Fumery, M ; Defrance, A ; Roblin, X...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i770-i770 , 2023
Link: https://doi.org/10.1093/..
 
?
9

P272 Tofacitinib as salvage therapy for patients hospitaliz..:

Uzzan, M ; Bresteau, C ; Laharie, D...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S305-S306 , 2021
Link: https://doi.org/10.1093/..
 
?
10

P593 Efficacy, tolerance and safety of low-volume bowel pre..:

Briot, C ; Faure, P ; Parmentier, A L...
Journal of Crohn's and Colitis.  12 (2018)  supplement_1 - p. S408-S408 , 2018
Link: https://doi.org/10.1093/..
 
?
11

Risk factors for EUS-guided radiofrequency ablation adverse..:

Napoléon, Bertrand ; Lisotti, Andrea ; Caillol, Fabrice...
Gastrointestinal Endoscopy.  98 (2023)  3 - p. 392-399.e1 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Efficacy and safety of combination targeted therapies in im..:

Guillo, Lucas ; Flachaire, Benoit ; Avouac, Jérôme...
Digestive and Liver Disease.  55 (2023)  1 - p. 61-68 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Cirrhotic patients with portal hypertension-related bleedin..:

Thabut, Dominique ; Pauwels, Arnaud ; Carbonell, Nicolas...
Journal of Hepatology.  68 (2018)  1 - p. 73-81 , 2018
Link: https://doi.org/10.1016/..
 
?
14

One-step endoscopic treatment of dysphagia in patients with..:

Pioche, Mathieu ; Mercky, Pascale ; Emungania, Olivier...
Gastrointestinal Endoscopy.  75 (2012)  3 - p. 690-691 , 2012
Link: https://doi.org/10.1016/..
 
?
15

Spontaneous resolution of severe, symptomatic mesocolic pan..:

Daumas, Aurélie ; Agostini, Serge ; Villeret, Julia...
BMC Gastroenterology.  12 (2012)  1 - p. , 2012
Link: https://doi.org/10.1186/..
 
1-15